NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002035

Registered date:29/06/2009

Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLC

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedNon-small cell lung cancer
Date of first enrollment2009/07/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TS-1:60mg/m2/day-80mg/m2/day

Outcome(s)

Primary OutcomeDisease control rate
Secondary OutcomeProgression free survival,Overall survival,Patient-Reported Outcome(PRO),Adverse events

Key inclusion & exclusion criteria

Age minimum75years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)History of severe allergy 2)Received surgery or radiotherapy to primary region 3)Use of other clinical trial drugs or phenytoin warfarin or flucytosine 4)Serious infection,SIADH,vena cava superior syndrome 5)Serious medical complications 6)Massive pleural effusion,ascites and penicardial effusion requires drainage 7)Symptomatic brain metastasis 8)Require radiotherapy to primary region 9)Concomitant malignancy 10)Intention to be pregnant in the future 11)Other clinical difficulties to this study

Related Information

Contact

public contact
Name Hisatsugu Goto
Address 3-18-15 Kuramoto-cho, Tokushima, Tokushima 770-8503, Japan Japan
Telephone 088-633-7127
E-mail hgoto@tokushima-u.ac.jp
Affiliation Institute of Health Biosciences,The University of Tokushima Graduate School Department of Respiratory Medicine & Rheumatology
scientific contact
Name Yasuhiko Nishioka
Address 3-18-15 Kuramoto-cho,Tokushima, Tokushima 770-8503, Japan Japan
Telephone 088-633-7127
E-mail yasuhiko@tokushima-u.ac.jp
Affiliation Institute of Health Biosciences,The University of Tokushima Graduate School Department of Respiratory Medicine & Rheumatology